{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:29:39Z","timestamp":1782890979678,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40292-020-00409-7","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T09:02:44Z","timestamp":1600506164000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of Treatment with Renin\u2013Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19"],"prefix":"10.1007","volume":"27","author":[{"given":"Martin","family":"Negreira-Caama\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Piqueras-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mart\u00ednez-DelRio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Nieto-Sandoval-Martin-DeLaSierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aguila-Gordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mateo-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Salas-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodriguez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7882-0469","authenticated-orcid":false,"given":"Mart\u00edn","family":"Negreira-Caama\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"issue":"10223","key":"409_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"15","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;15(10223):497\u2013506.","journal-title":"Lancet"},{"key":"409_CR2","doi-asserted-by":"crossref","unstructured":"Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR (2020) Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents","DOI":"10.1016\/j.ijantimicag.2020.106024"},{"issue":"19","key":"409_CR3","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/eurheartj\/ehaa231","volume":"18","author":"T-Y Xiong","year":"2020","unstructured":"Xiong T-Y, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020 Mar;18(19):1798\u2013800. 41(.","journal-title":"Eur Heart J"},{"issue":"22","key":"409_CR4","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/eurheartj\/ehaa447","volume":"41","author":"AS Jaffe","year":"2020","unstructured":"Jaffe AS, Cleland JGF, Katus HA. Myocardial injury in severe COVID-19 infection. Eur Heart J. 2020;41(22):2080\u20132.","journal-title":"Eur Heart J"},{"issue":"22","key":"409_CR5","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/eurheartj\/ehaa447","volume":"41","author":"AS Jaffe","year":"2020","unstructured":"Jaffe AS, Cleland JGF, Katus HA. Myocardial injury in severe COVID-19 infection. Eur Heart J. 2020;41(22):2080\u20132.","journal-title":"Eur Heart J"},{"issue":"8","key":"409_CR6","doi-asserted-by":"publisher","first-page":"e1007236","DOI":"10.1371\/journal.ppat.1007236","volume":"14","author":"W Song","year":"2018","unstructured":"Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLOS Pathogens. 2018;14(8):e1007236.","journal-title":"PLOS Pathogens"},{"key":"409_CR7","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280.e8","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"409_CR8","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","volume":"41","author":"GM Kuster","year":"2020","unstructured":"Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Pathophysiology. Eur Heart J. 2020;41:1801\u20133.","journal-title":"Eur Heart J"},{"issue":"20","key":"409_CR9","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605\u201310.","journal-title":"Circulation"},{"issue":"19","key":"409_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","volume":"41","author":"IE Sama","year":"2020","unstructured":"Sama IE, Ravera A, Santema BT, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41(19):1810\u20137.","journal-title":"Eur Heart J"},{"issue":"22","key":"409_CR11","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","volume":"41","author":"C Gao","year":"2020","unstructured":"Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J. 2020;41(22):2058\u201366.","journal-title":"Eur Heart J"},{"issue":"12","key":"409_CR12","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"5","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J, et al. Association of inpatient use of Angiotensin-converting enzyme inhibitors and Angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;5(12):1671\u201381.","journal-title":"Circ Res"},{"key":"409_CR13","doi-asserted-by":"crossref","unstructured":"Khera R, Clark C, Lu Y, Guo Y, Ren S, Truax B et al (2020) Association of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with the risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19. MedRxiv: the preprint server for health sciences Cold Spring Harbor Laboratory Press (2020.05.17.20104943)","DOI":"10.1101\/2020.05.17.20104943"},{"issue":"33","key":"409_CR14","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"25","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;25(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"7","key":"409_CR15","doi-asserted-by":"publisher","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","volume":"9","author":"R Sommerstein","year":"2020","unstructured":"Sommerstein R, Kochen MM, Messerli FH, Gr\u00e4ni C. Coronavirus Disease 2019 (COVID-19): do Angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect? J Am Heart Assoc. 2020;9(7):e016509.","journal-title":"J Am Heart Assoc"},{"key":"409_CR16","doi-asserted-by":"crossref","unstructured":"Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis.\u00a0http:\/\/coronavirus.jhu.edu\/map\/html.","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"409_CR17","doi-asserted-by":"crossref","unstructured":"Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, et al (2020) Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19: much Ado for Nothing? A statement of activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev 27(2):105\u20138.","DOI":"10.1007\/s40292-020-00380-3"},{"issue":"18","key":"409_CR18","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"30","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;30(18):1708\u201320.","journal-title":"N Engl J Med"},{"key":"409_CR19","doi-asserted-by":"crossref","unstructured":"Li J, Wang X, Chen J, Zhang H, Deng A (2020) Association of Renin-Angiotensin system inhibitors with severity or risk of death in patients with hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol:23","DOI":"10.1001\/jamacardio.2020.1624"},{"issue":"9","key":"409_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"4","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income Countries. JAMA. 2013;4(9):959\u201368.","journal-title":"JAMA"},{"issue":"22","key":"409_CR21","first-page":"2344","volume":"29","author":"W Zengwu","year":"2018","unstructured":"Zengwu W, Zuo C, Linfeng Z, Xin W, Guang H, Zugui Z, et al. Status of hypertension in China. Circulation. 2018;29(22):2344\u201356.","journal-title":"Circulation"},{"issue":"2","key":"409_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","volume":"76","author":"G Iaccarino","year":"2020","unstructured":"Iaccarino G, Grassi G, Borghi C, et al. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension. Hypertension. 2020;76(2):366\u201372.","journal-title":"Hypertension"},{"key":"409_CR23","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. 2020;8:e21.","journal-title":"Lancet Respir"},{"key":"409_CR24","unstructured":"Situaci\u00f3n de (2020) COVID-19 en Espa\u00f1a. Ministerio de Sanidad. Consulted 2020 Jun 12. https:\/\/covid19.isciii.es."}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-020-00409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-020-00409-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-020-00409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:16:15Z","timestamp":1632010575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-020-00409-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s40292-020-00409-7","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,19]]},"assertion":[{"value":"19 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflict of interest regarding the present investigation work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by an Ethics Committee that declined the need of informed consent due to the observational nature of the study and the pandemic situation, recognising an increased risk of infection due to unnecessary human contact.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}